Explore the Value of Adding Induction Chemotherapy to Concurrent Chemoradiotherapy in T3-4N0M0 Nasopharyngeal Carcinoma Patients: A Retrospective Study

PURPOSE: Patients with T3-4N0M0 nasopharyngeal carcinoma (NPC) are a unique subgroup of locoregional advanced NPC, which generally have a better prognosis than others and are often excluded in most randomized controlled clinical trials focusing on locoregional advanced NPC. The management of this po...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Peijing, Zhang, Qun, Luo, Donghua, Jiang, Feng, Jin, Qifeng, Hua, Yonghong, Jin, Ting, Chen, Xiaozhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437383/
https://www.ncbi.nlm.nih.gov/pubmed/34526821
http://dx.doi.org/10.2147/CMAR.S321471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437383/
https://www.ncbi.nlm.nih.gov/pubmed/34526821
http://dx.doi.org/10.2147/CMAR.S321471

Ejemplares similares